Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque).
D000284:Administration, Oral; D000328:Adult; D000409:Alanine / Q000008:administration & dosage / Q000009:adverse effects; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D002765:Cholecystography; D002934:Cinnamates / Q000008:administration & dosage / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects; D005069:Evaluation Studies as Topic; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007462:Iodobenzenes / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D014556:Urine
D002934:Cinnamates; D003287:Contrast Media; D006454:Hemoglobins; D007462:Iodobenzenes; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D000409:Alanine